CH

CHARLES HUSSER

ARTHRITIS FOUNDATION · WASHINGTON, DC · registered since 2024
Registered · LDAActive

At a glance

Registered since
2024
Senate LDA system
Clients
1
last 3 years
Filings
6
10 agencies contacted
Activity
filings by quarter
Works on

Background

Government experience
Federal Affairs Manager
Disclosed on LD-2 filings
Career
WASHINGTON, DC
2024 - present

Specific issues

CDC Arthritis Program - Appropriations Congressionally Directed Medical Research Program - Appropriations
Budget/Appropriations · 2025 Q1
S.46 - Health Care Affordability Act of 2025 Safe Step Act S.864 - HELP Copays Act CDC Arthritis Program - Appropriations Congressionally Directed Medical Research Program - Appropriations ATPCs Arthritis Research Medicaid
Health Issues · 2025 Q1
-HR 830 / S 1357, HELP Copays Act -HR 2630 / S 652, Safe Step Act -S 1339, Pharmacy Benefit Manager Reform Act -H.R. 1770, the Equitable Community Access to Pharmacist Services Act -HR 824, the Telehealth Benefit Expansion for Workers Act -Accelerating Kids Access to Care Act - S. 127 Pharmacy Benefit Manager Transparency Act of 2023 - S. 1339 Pharmacy Benefit Manager Reform Act - H.R. 4507 Transparency in Coverage Act of 2023 - H.R. 4822 Health Care Price Transparency Act of 2023 - H.R. 3561 PATIENT Act of 2023 -H.R. 5378 - The Lower Costs, More Transparency Act - H.R. 2761 SPARC Act, Specialty Physicians Advancing Rural Care (SPARC) Act - S.1701/H.R.3503 NIH Clinical Trial Diversity Act of 2023 - H.R. 1114 Long COVID RECOVERY NOW Act - S.2840 the Bipartisan Primary Care and Health Workforce Act - Reducing Drug Prices for Seniors Act - Improving Seniors Timely Access to Care Act - Health Care Affordability Act
Health Issues · 2024 Q4
FY24 Appropriations - PSLRP and CDRMP for Arthritis, NIH and CDC, improving osteoporosis care and awareness H.R.9747 - Continuing Appropriations and Extensions Act, 2025
Budget/Appropriations · 2024 Q4
out-of-pocket costs, drug prices, utilization management, prior authorization, step therapy, clinical trial diversity, COVID-19 therapeutics, pharmacist scope of practice, telehealth extensions , association health plans, self-insurance protections, short-term limited duration insurance plans, Pharmacy Benefit Managers, -HR 830/S 1357,HELP Copays Act -HR 2630/ S. 652, Safe Step Act -S 1339, Pharmacy Benefit Manager Reform Act -HR 1770, the Equitable Community Access to Pharmacist Services Act -HR 824, the Telehealth Benefit Expansion for Workers Act -Accelerating Kid's Access to Care Act -Reducing Drug Prices for Seniors Act - Health Care Affordability Act - H.R.9747 - Continuing Appropriations and Extensions Act, 2025
Medicare/Medicaid · 2024 Q4
FY24 Appropriations - PSLRP and CDRMP for Arthritis, NIH and CDC, improving osteoporosis care and awareness
Budget/Appropriations · 2024 Q3

Clients

2024-2025 · 6 filings
$██,███ / qtrUnlock

Filing history

2025 Q1
ARTHRITIS FOUNDATION
Q1lda.gov →
2024 Q4
ARTHRITIS FOUNDATION
Q4lda.gov →
2024 Q3
ARTHRITIS FOUNDATION
Q3lda.gov →
2024 Q2
ARTHRITIS FOUNDATION
Q2lda.gov →
2024 Q1
ARTHRITIS FOUNDATION
1Alda.gov →
2024 Q1
ARTHRITIS FOUNDATION
Q1lda.gov →
Showing recent filings · full history on lda.gov